The human cerebral cortex is affected by a wide range of disorders and is also particularly sensitive to the effects of drugs and environmental toxins during development. Human pluripotent stem cells (hPSCs) are a unique system to model the human cerebral cortex, but replicating the complexity of this structure in terms of both neuronal diversity and developmental processes has been limited in current models. Here, Chun-Ting Lee and colleagues use hPSC aggregates without cell dissociation but with inclusion of key trophic factors to model human neocortical development. They are able to reproduce in vitro the formation of radial glia scaffolding (which supports neuronal migration), of deep and upper layers of cortical neurons, and of different neuronal subtypes (including glutamatergic and GABAergic neurons), as occurs during human neocortical development. In addition, the authors use this system to study the effects of cocaine – a drug that causes developmental toxicity in humans – and find that it induces oxidative stress and impairs both neuronal differentiation and layer patterning. Notably, these changes are reversed by cimetidine, a cytochrome P450 inhibitor. This model represents a valuable system to study human neocortical development, its susceptibility to toxins and also to identify potential compounds to prevent drug-induced neocortical impairments. Page 1397
Modelling drug-induced neocortical toxicity in vitro
- Split-screen
- Views Icon Views
-
Article Versions Icon
Versions
- Version of Record 01 December 2014
- Share Icon Share
-
Tools Icon
Tools
- Search Site
Modelling drug-induced neocortical toxicity in vitro. Dis Model Mech 1 December 2014; 7 (12): e1201. doi:
Download citation file:
Advertisement
Cited by
New Special Issue: Translating Multiscale Research in Rare Disease. Edited by Monica Justice, Monkol Lek, Karen Liu and Kate Rauen.
This special issue features original Research, Resources & Methods and Review-type articles that aim to interrogate the mechanisms of rare diseases to foster meaningful clinical progress in their diagnosis and treatment.
The role of the International Society for Stem Cell Research (ISSCR) guidelines in disease modelling
The ISSCR provides comprehensive guidelines and standards for using human stem cells in biomedical research. In this Editorial, Cody Juguilon and Joseph Wu discuss how and why these should be incorporated in disease modelling research.
Subject collection: Building advocacy into research
DMM’s series - Building advocacy into research - features interviews, ‘The Patient’s Voice’, with patients and advocates for a range of disease types, with the aim of supporting the highest quality research for the benefit of all patients affected by disease.
Read & Publish Open Access publishing: what authors say
We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.
Biologists @ 100 - join us in Liverpool in March 2025
We are excited to invite you to a unique scientific conference, celebrating the 100-year anniversary of The Company of Biologists, and bringing together our different communities. The conference will incorporate the Spring Meetings of the BSCB and the BSDB, the JEB Symposium Sensory Perception in a Changing World and a DMM programme on antimicrobial resistance. Find out more and register your interest to join us in March 2025 in Liverpool, UK.
Other journals from
The Company of Biologists